Inflammasomes survey the cytosol for signs of perturbation or bacterial contamination and initiate inflammation during microbial defense or inflammatory diseases. The NLRC4 inflammasome detects the activity of bacterial type III secretion systems (T3SS) as well as flagellin, and then activates caspase-1, which processes IL-1? and IL-18 to their mature forms, and initiates a form of programmed lytic cell death called pyroptosis to prevent the establishment of an intracellular replication niche. Caspase-11, the non-canonical inflammasome, detects LPS in the cytosol and triggers pyroptosis, but cannot process pro-IL-1? or IL-18 alone. Using Burkholderia thailandensis, a model for the cytosol invasive select agent Burkholderia pseudomallei, I found that B. thailandensis is primarily cleared via caspase-11, while caspase-1 plays a minor role in defense. Specifically, I found that caspase-1 activation by the T3SS provides a priming signal, IL-18-induced IFN-?, upstream of caspase-11 expression during defense against B. thailandensis, leading to clearance in 24 hours. By contrast, in the absence of caspase-1-driven IL-18, bacterial burdens persist for several days, eventually triggering other signals that induce IFN-? and downstream caspase-11 expression. In this proposal, I will investigate why caspase-1 and -11 dependent pyroptosis are not equivalent, and what is the cellular source of IFN-? that prime caspase-11 to protect against B.thailandensis. These studies will provide new insights into the mechanisms behind inflammasome-mediated defense against infection, and thus aid future treatments aimed at therapeutic manipulation of the host innate immune system.

Public Health Relevance

The experiments in this proposal focus on the inflammasome, an innate immune system signaling mechanism that regulates inflammation during infection and inflammatory diseases. The inflammasome detects bacterial infection and activates caspase-1 or caspase-11 to trigger pyroptosis, a lytic programed cells death. I will examine the caspase-1 and -11 inflammasome-coordinated responses in defense against intracellular pathogens in order to identify therapeutic targets for the treatments of infectious diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Career Transition Award (K22)
Project #
1K22AI132489-01
Application #
9370526
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2018-08-02
Project End
2020-07-31
Budget Start
2018-08-02
Budget End
2019-07-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205